Best GLP-1 Weight Loss Programmes for Women in the UK (2026)

The best GLP-1 weight loss programme for women in the UK is one that is designed for how the female body works, one that prescribes clinically approved medication, includes blood testing before you start, and has a real clinician making your dose decisions. In 2026, that shortlist is short and SheMed sits at the top of it.

2026 is a landmark year for women wanting to start a weight loss transformation in the UK. We now have three licensed GLP-1 medication formats: the Wegovy injection, Mounjaro injection and the newly MHRA-approved Wegovy daily pill.

There are over 2.5 million people in the UK accessing some kind of GLP-1 medication privately every month as of early 2026. This number is only meant to increase with the increased research and the resultant efficacy in this sector.

However, more options means more decisions and not all programmes are created equal. In this guide, we have honestly reviewed the leading GLP-1 treatment programme options.

Now before we jump on to the comparison of programmes, let’s start with the basics. For those who are already aware of what GLP-1 medications are can skip this part.

‍

What Is a GLP-1 Weight Loss Medication?

GLP-1 is an abbreviation for glucagon-like peptide -1. It is a hormone that your gut naturally releases after eating to tell your brain that you’re full, and thus to slow down digestion and regulate blood sugar.

GLP-1 medications are synthetic versions of this very same hormone. The key difference, though, is that the naturally these hormones last in your body for a few minutes, while these medications have been engineered to last for days.

The result: appetite comes down, the constant food chatter quietens, and sustained weight loss becomes possible in a way it simply wasn’t before this medication class existed.

They’re prescription-only medicines, licensed and monitored by the MHRA. They work on the biology of appetite rather than trying to override it through willpower alone.

For a fuller explanation, read how GLP-1 peptides work →

‍

Now there are three main GLP-1 treatments that are legally available in the UK -

·      Wegovy pill (oral semaglutide):

This is the latest (MHRA-approved 11 June 2026) and the first oral GLP-1 weight loss tablet licensed in the UK. The clinical trial data (OASIS 4, NEJM 2025) showed an average body weight loss of 16.6% at 64 weeks.

·  Wegovy injection (semaglutide):

This is the benchmark weekly GLP-1 injection. Its clinical trial (STEP 1) showed an average weight loss of 14.9% and up to 20.7% with the newly approved 7.2mg dose (STEP UP, Lancet 2025). It is also the only weight loss injection licensed to reduce cardiovascular risk (NICE, April 2026).

·      Mounjaro injection (tirzepatide):

This is the one that works on a dual mechanism, GLP-1 and GIP, activating two appetite-regulating hormones simultaneously. By far, it has shown the highest average weight loss results in a clinical trial with 22.5% average weight loss at 72 weeks (SURMOUNT-1, NEJM 2022).

Read a detailed comparison of Mounjaro vs Wegovy.

Now the part that you’ve been waiting for.

The Best GLP-1 Weight Loss Programmes for Women in the UK (2026)

There are many providers in the UK that offer GLP-1 medications. But few that offer a programme tailored specifically for women.

1. SheMed: The UK’s Only Medicated Weight Loss Programme Built Exclusively for Women

With two strong female founders, SheMed was built from the ground up around female physiology.

Every part of the clinical model including the blood test panel, the dose decision process, the support built into each plan is designed with women in mind. This is important because there are factors like PMOS, perimenopause, thyroid conditions, hormonal factors, etc. that only women face, that affect weight management directly. These aren’t afterthoughts at SheMed, they’re baked into the clinical assessment.

•       All three treatment formats: We offer all three licensed GLP-1 formats including Wegovy pill, Wegovy injection, and Mounjaro injection.

•       Free at-home blood test worth £100: We don’t prescribe anything blindly. We will check for thyroid function, liver enzymes, HbA1c, and cholesterol before any treatment is prescribed.

•       Clinician-led dose decisions: We’ve got a real good team of clinicians that will review your blood results and history before every dose recommendation.

•       Side-effect care pack included: in your first month, because side effects are real. And just like your best friend, we won’t leave you alone when you go through them.

•       Repeat blood tests at 6 and 12 months: Because we want to take care of your holistic health and not just your weight.

2. Voy

Voy is a mixed-gender programme with a dedicated women’s track. It offers a broad range of medications, Mounjaro, Wegovy, Wegovy pill, Saxenda, and Orlistat. It also provides app-based coaching and clinical support.

Pricing varies and its clinical design is gender-neutral rather than female-specific, which means women with hormonal factors or PCOS-related weight management challenges may find the approach less tailored than they’d like.

‍

3. Juniper

Juniper is a women-leaning programme with an app-based model. It offers structured health coaching, nutrition guidance, and community support alongside the medication. It has Mounjaro, Wegovy and the Wegovy pill.

The pricing starts from around £164/month making it one of the pricier options. Clinical oversight is provided by pharmacist independent prescribers rather than doctors. We would say it is strong on coaching and community but a bit lighter on clinical depth compared to SheMed.

‍

4. For Hers

For Hers is a US originated company with a presence in the UK. While the name may sound that it’s only for women, its clinical pathway is less established in UK-specific governance terms. The pricing and clinical oversight are less transparent compared to UK-founded programmes.

5. Curate Health

Curate Health is a new entrant in the UK GLP-1 weight loss offering space. It comes with a focus on females. It has a smaller community and less published clinical outcome data than more established providers. However, it may be worth keeping a watch on it as the market develops.

6. Second Nature

Second nature comes with strong NHS-partnership credentials. It tilts on the side of behaviour-change-first model with a decade of experience in weight management coaching. It now incorporates GLP-1 medications alongside its existing coaching programme.

We would say it is better suited to women who want a structured habit-building framework than those primarily seeking clinically tailored, female-specific medical oversight.

7. Boots Online Doctor

Boots is the big player in the market that comes with brand recognition and accessibility. It offers GLP-1 medications after a clinical assessment, but there is no structured women’s weight loss programme around the medication. It also does not include a free blood test, female-specific clinical pathway, and a side-effect care pack as standard.

We would say it is more of a prescription service rather than a programme.

How to Choose the Right GLP-1 Programme as a Woman in the UK

There are a few fundamental questions that you need to ask before choosing the right programme for you. They include –

•       Is it designed for female physiology? A women’s body is very different to a man’s and because of factors like PCOS, perimenopause, and cycle-related appetite, it responds to weight loss medications differently as well. A programme that treats men and women identically may not be the best choice.

•       What’s included beyond the medication? Blood tests, clinician reviews, side-effect support, and repeat monitoring are the things that protect you. Don’t look at them like some complimentary gift cards that you’re never going to need. They are proofs for the programme being thoughtful towards you. Some providers charge separately or don’t include at all.

•       Who is making your dose decisions? A clinician who reviews your history vs an automated questionnaire can account for a meaningful clinical difference. Ask.

•       What is the true monthly cost? Headline prices rarely include consultation fees, blood tests, needles, or delivery. Please make sure you calculate the total before committing.

•       Can you access all three formats? If you’re needle-averse now but want to try the pill later, or want to switch between formats, choose a programme that offers flexibility.

Related reading: weight loss pills that actually work in the UK →

Related reading: how to switch between Mounjaro and Wegovy →

‍

GLP-1 Programme Comparison Table

‍

Frequently Asked Questions

What is the best GLP-1 weight loss programme for women in the UK?

SheMed is the only UK programme designed exclusively around female physiology, offering all three GLP-1 treatment formats including Wegovy pill, Wegovy injection, and Mounjaro. Pricing starts from £59/month, including a free blood test and personalised clinician-led care.

Are weight loss pills the same as GLP-1 injections?

No. Traditional weight loss pills work differently from GLP-1 medications. The Wegovy pill, approved by the MHRA in June 2026, is the first oral GLP-1 weight loss tablet in the UK and contains the same active ingredient, semaglutide, as the Wegovy injection.

What is the strongest weight loss prescription available in the UK?

Mounjaro (tirzepatide) currently offers the highest results with 22.5% average body weight loss at 72 weeks as per clinical trials. However, every journey is unique, and the results can hence differ from person to person.

How much do GLP-1 weight loss programmes cost in the UK?

Costs vary significantly across providers. SheMed plans start from £59/month and include a free blood test worth £100, personalised clinical care, and a side-effect support pack. Juniper starts from £164/month, with clinical oversight provided by pharmacist prescribers. All costs may not be mentioned upfront by all suppliers. It is best to check what’s included in the stated price before comparing.

Are GLP-1 programmes safe for women?

GLP-1 medications are clinically approved and safe for eligible adults when prescribed and monitored by a qualified clinician. Women who are pregnant, planning to conceive, or have specific conditions including active eating disorders or certain thyroid cancers may not be eligible. SheMed begins with a thorough clinical assessment which includes blood testing before prescribing anything.

Sources & Further Reading

1. NICE TA875 — Semaglutide for Weight Management

2. NICE TA1026 — Tirzepatide (Mounjaro) for Overweight and Obesity

3. Wilding JPH et al. — STEP 1. NEJM. 2021;384(11):989–1002

4. Jastreboff AM et al. — SURMOUNT-1. NEJM. 2022;387(3):205–216

5. Wharton S et al. — OASIS 4. NEJM. 2025;393(11):1077–87

6. NICE — Semaglutide for Cardiovascular Risk (April 2026)

7. MHRA — GLP-1 Medicines for Weight Loss (GOV.UK, updated 2026)

8. NHS — Obesity Treatment Overview

9. Diabetes UK — GLP-1 Receptor Agonist Explainer

10. Novo Nordisk — Wegovy Pill UK MHRA Approval (11 June 2026)

11. STEP 1 — Wilding JPH et al. NEJM. 2021;384(11):989–1002

12. SURMOUNT-1 — Jastreboff AM et al. NEJM. 2022;387(3):205–216

13. OASIS 4 — Wharton S et al. NEJM. 2025;393(11):1077–87

‍